Risk factor | No. of patients | % of patients† |
---|---|---|
Recipient age at transplant, yr, mean ± SD | 1667 | 51.4 ± 13.4 |
Recipient sex, male | 1017 | 61.0 |
Recipient race | ||
White | 900 | 61.2 |
Black or African Canadian | 167 | 11.4 |
East Asian | 190 | 12.9 |
South Asian | 162 | 11.0 |
Indigenous | 27 | 1.8 |
Pacific Islander | 24 | 1.6 |
Recipient BMI, kg/cm2, mean ± SD | 1599 | 27.1 ± 5.6 |
Recipient history of diabetes mellitus | 522 | 31.3 |
Recipient history of vascular disease‡ | 478 | 28.7 |
Time on dialysis before transplant, yr, median (IQR) | 1667 | 3.3 (1.3–5.8) |
Peak PRA | ||
0% | 795 | 47.8 |
> 0% | 870 | 52.3 |
Donor age at donation, yr, mean ± SD | 1664 | 47.5 ± 14.5 |
Donor type | ||
Living | 774 | 46.4 |
Deceased, ECD | 308 | 18.5 |
Deceased, non-ECD | 585 | 35.1 |
Delayed graft function | ||
Yes | 360 | 21.6 |
Regraft | ||
Yes | 182 | 10.9 |
Cold ischemic time, h (deceased donor only), median (IQR) | 831 | 10.9 (7.9–14.8) |
DVT prophylaxis | ||
Yes | 849 | 50.9 |
Type of induction | ||
Nondepleting agent | 415 | 24.9 |
Depleting agent | 1252 | 75.1 |
Transplant era | ||
2005–2009 | 621 | 37.3 |
2010–2013 | 564 | 33.8 |
2014–2016 | 482 | 28.9 |
BMI = body mass index, DVT = deep vein prophylaxis; ECD = expanded criteria donor; IQR = interquartile range; PRA = panel reactive antibodies; SD = standard deviation.
↵* The origin is the transplant date, and the outcome variable is early DVT (DVT within 3 mo of transplant).
↵† Unless indicated otherwise.
↵‡ Includes recipient history of coronary artery disease, recipient history of peripheral vascular disease, recipient history of congestive heart failure and recipient history of stroke.